Dear all,
What are the possible reasons if the treatment vs control finds very very few significant DEGs(padj < 0.05, abs(log2FC) > 1) ?
The PCA plot also shows that the control group and treatment group samples are mixed together...
Thank you very much!
To add some detail to the first point - its essential to validate your in silico results with in vitro ones. Did the cells change in morphology after treatment? Is there a good reason to believe that the treatment was indeed effective?
Thanks a lot!
The experimental side states have found changed phenotype....
Thanks a lot!
We have 3 replicates for control, and 3 replicates for treatment.
The 3 replicates are distant from each other in the 3D PCA, while for each replicate, the control and treatment are so close(seems the antibody effects are so small).
After DEseq2 and limma, and then the enrichment analysis, both pathways' annotations are very similar, and DEGs are all very very few(below 10) after padj < 0.05 and abs(log2FC) >1. Also checked several times of the code, and did not find an obvious bug to date....
What are you comparing? If you describe your setup a bit more one might come up with a more powerful design. Is this a paired analysis, so do you have like three donors and you expose cells from it to a treatment or mock?